Concurrent Investment Advisors LLC grew its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 1.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 33,267 shares of the financial services provider’s stock after buying an additional 325 shares during the period. Concurrent Investment Advisors LLC’s holdings in Aflac were worth $3,719,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in AFL. Y.D. More Investments Ltd acquired a new position in Aflac in the 2nd quarter valued at about $25,000. Cedar Wealth Management LLC acquired a new position in shares of Aflac in the first quarter valued at approximately $50,000. Catalyst Capital Advisors LLC purchased a new position in shares of Aflac during the third quarter valued at approximately $51,000. Fairscale Capital LLC acquired a new stake in Aflac during the second quarter worth approximately $54,000. Finally, Valued Wealth Advisors LLC grew its stake in Aflac by 116.7% in the 3rd quarter. Valued Wealth Advisors LLC now owns 479 shares of the financial services provider’s stock worth $54,000 after acquiring an additional 258 shares during the period. 67.44% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
AFL has been the topic of several research analyst reports. TD Cowen initiated coverage on shares of Aflac in a research report on Wednesday, October 9th. They issued a “hold” rating and a $102.00 target price on the stock. UBS Group raised their price objective on Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a report on Wednesday, August 14th. Citigroup increased their target price on shares of Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 23rd. Piper Sandler boosted their price objective on shares of Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Finally, Wells Fargo & Company increased their price objective on shares of Aflac from $106.00 to $107.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, Aflac presently has a consensus rating of “Hold” and a consensus target price of $97.93.
Aflac Stock Performance
Shares of AFL opened at $108.56 on Thursday. Aflac Incorporated has a 52-week low of $75.07 and a 52-week high of $115.50. The company has a quick ratio of 0.10, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. The firm has a market cap of $60.80 billion, a price-to-earnings ratio of 16.35, a PEG ratio of 2.07 and a beta of 0.96. The business’s 50 day moving average is $110.42 and its two-hundred day moving average is $98.32.
Aflac (NYSE:AFL – Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. The firm had revenue of $2.95 billion for the quarter, compared to the consensus estimate of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The firm’s revenue was down 40.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.84 EPS. Analysts forecast that Aflac Incorporated will post 7.05 EPS for the current fiscal year.
Aflac Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.84%. The ex-dividend date is Wednesday, November 20th. Aflac’s payout ratio is currently 30.12%.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Recommended Stories
- Five stocks we like better than Aflac
- What Do S&P 500 Stocks Tell Investors About the Market?
- What a Trump Win Looks Like for the Market Now and Into 2025
- Best Aerospace Stocks Investing
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Most Volatile Stocks, What Investors Need to Know
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.